Sensitive technologies
Officials and experts discussed biomedical product drivers
[PharmVestnik # 01, 17/01/2017, p. 1, cont’d p. 8]
Key pharma industry events of 2016
PharmVestnik presents a traditional new year review of the key news of the past year as well as of their effect on the pharma industry. The status of forecasts made throughout the year is reviewed as well.
[PharmVestnik # 01, 17/01/2017, pp. 2-5]
Time for “harvesting”
Experts hope that regulators will be wise this year
Nobody has ever said that the year 2016 was going to be easy for Russia as a whole, and for pharma industry in particular. However, when summing up the year results, experts stated that many expectations have failed to be met. It goes both about the initiatives that were welcome for the industry and those detrimental, in the opinion of most pharma industry players. Within the framework of the final in 2016 meeting of the Russian Association of Pharmaceutical Marketing, the lead experts attempted at analysis of how the current situation might affect the industry’s future development.
[PharmVestnik # 01, 17/01/2017, pp. 6-7]
Smart money
IT and pharma make bonds
IT mainstreaming is presently one of the key development factors for pharma that determines the industry future. However, it is premature to state that IT and pharma successfully collaborate. Representatives of Russian and international pharma companies as well as R&D teams in the field of intellectual data analysis discussed cooperation prospects and areas within the framework of the workshop “Big data and decision-making support systems for pharma” hosted by the national Technology Initiative and Semantic Hub.
[PharmVestnik # 01, 17/01/2017, p. 9]
Keep calm
Major Russian pharmaceutical manufacturing site have already passed GMP compliance inspections
The pharma industry is among the government priorities. The Ministry of Industry and Trade continuously works on support measures for Russian pharmaceutical and medical device manufacturers. Olga KOLOTILOVA, Director of Pharmaceutical and Medical Industry Development Department of the Russian Ministry of Industry and Trade, enlarges on the ministry’s top agenda.
[PharmVestnik # 01, 17/01/2017, p. 11]
Dietary supplement manufacturers rush to self-management amid crackdown
In the end of 2016, a Russian Government meeting covered the issue of granting additional opportunities via voluntary certification for self-managing dietary supplement manufacturers. PharmVestnik received this information first hand from a relevant service provider. It is expected that this will allow to place additional information on the supplement package labels, which is an important competitive advantage. Amid the tightening crackdown on supplement manufacturers, the latter may find such arrangement to be a pressure breaker. However, certain market players fear that self-management will not protect against harassment by the Federal Antimonopoly Service and other regulators that may ignore the decisions of self-management organizations.
[PharmVestnik # 01, 17/01/2017, p. 12]
Made in Kurgan
Velpharm launched a pharmaceutical factory
On December 22nd, 2016, Velpharm launched a finished drug manufacturing facility in Kurgan, which is of key importance for the entire Russian pharma industry. PharmVestnik visited the launch ceremony at the facility that may evolve as one of the industry leaders in Russia competing with foreign manufacturers.
[PharmVestnik # 01, 17/01/2017, p. 15]
State drug bidding report, Q316
The state bidding sector is of interest due to several factors such as growth as a whole; a new rating leader among the Russian Federal districts; and change of the assembly lots percentage.
[PharmVestnik # 01, 17/01/2017, pp. 18-19]
Transfer to goods purchasing pursuant to Federal law 44-FZ may trigger bankruptcy of state and municipal pharmacies
The year 2017 may be fatal for state and municipal pharmacies. From January 1st, they will procure products under Federal law 44-FZ. The only survivors will be those capable of changing their type of legal entity shortly. The rest enter into long-term agreements with suppliers, and forecast bankruptcy of state pharmaceutical retailers in near future.
[PharmVestnik # 01, 17/01/2017, p. 20]
Scientists of Perm State R&D University received a Presidential grant for dioxoheterocycles studies
For quite a while, Perm State Research and Development University has been coming up with inventions and receiving government support for further development of promising projects.
[PharmVestnik # 01, 17/01/2017, p. 21]
